Whole-Body Vibration Therapy in the Gait of Children With Cerebral Palsy
NCT ID: NCT06314776
Last Updated: 2024-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
10 participants
INTERVENTIONAL
2024-03-11
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-Usual physiotherapy
Pre-intervention (GMFM, Test 10M, Test Time Up and Go)
Pre-Usual physiotherapy
(GMFM, Test 10M, Test Time Up and Go)
Usual physiotherapy without Whole-Body Vibration
Two days a week of physical therapy (mobilizations, manual therapy, stretching, respiratory techniques)
Usual physiotherapy without Whole-Body Vibration
Manual Therapy, passive and active mobilizations, stretching, respiratory techniques
Post-Usual physiotherapy
Post-intervention (GMFM, Test 10M, Test Time Up and Go)
Post-Usual physiotherapy
(GMFM, Test 10M, Test Time Up and Go)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Usual physiotherapy without Whole-Body Vibration
Manual Therapy, passive and active mobilizations, stretching, respiratory techniques
Pre-Usual physiotherapy
(GMFM, Test 10M, Test Time Up and Go)
Post-Usual physiotherapy
(GMFM, Test 10M, Test Time Up and Go)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 2 to 11 years.
* GMFCS I and II.
* Assessed and/or intervened in or from centers, institutions, etc. who collaborate with the University of Almería or participate in them. Specifically from the "Interactúa" Child Development and Early Care Center.
* The subject, father/mother/legal guardian of each subject, prior to inclusion in the study, must have signed the informed consent for the participation of himself or his/her child in it, leaving a record that it could be abandoned if at any time they deem it appropriate and without having to justify it.
Exclusion Criteria
* Serious blood circulation problems.
* Recent operations.
* Prosthetics.
* Start of another type of therapy different from the current one.
* Not having indication for Physiotherapy.
2 Years
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Almeria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
María del Mar Sánchez Joya
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
María del Mar Sánchez-Joya
Almería, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Maria del Mar Sanchez Joya, PhD
Role: CONTACT
Phone: 627445787
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
María del Mar Sánchez-Joya, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEURO24
Identifier Type: -
Identifier Source: org_study_id